SAIBA GMBH has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in Singapore, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology and pharmaceuticals are MOLOGEN FORSCHUNGS ENTWICKLUNG, AGRICULTURAL TECH RES INST and IMNATE SARL.
# | Country | Total Patents | |
---|---|---|---|
#1 | Singapore | 2 | |
#2 | United States | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | Chile | 1 | |
#8 | China | 1 | |
#9 | EPO (European Patent Office) | 1 | |
#10 | Israel | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Mexico | 1 | |
#13 | Peru | 1 | |
#14 | Philippines | 1 | |
#15 | Tunisia | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Zeltins Andris | 15 |
#2 | Pumpens Paul | 14 |
#3 | Bachmann Martin | 14 |
#4 | Paul Pumpens | 2 |
#5 | Andris Zeltins | 2 |
#6 | Martin Bachmann | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020128037A1 | Virus-like particles of cmv modified by fusion | |
AU2015335027A1 | Modified virus-like particles of CMV |